Belpointe Asset Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$482K Sell
5,659
-2,339
-29% -$208K 0.02% 694
2025
Q4
$632K Buy
7,998
+1,818
+29% +$143K 0.02% 582
2025
Q3
$494K Sell
6,180
-2,973
-32% -$254K 0.02% 634
2025
Q2
$832K Sell
9,153
-2,294
-20% -$209K 0.03% 416
2025
Q1
$1.07M Buy
11,447
+3,798
+50% +$340K 0.06% 317
2024
Q4
$815K Sell
7,649
-141
-2% -$13.5K 0.05% 372
2024
Q3
$809K Buy
7,790
+724
+10% +$73.8K 0.05% 360
2024
Q2
$686K Sell
7,066
-2,774
-28% -$256K 0.05% 374
2024
Q1
$886K Buy
9,840
+4,288
+77% +$363K 0.07% 299
2023
Q4
$443K Buy
5,552
+621
+13% +$46.7K 0.04% 400
2023
Q3
$351K Buy
4,931
+68
+1% +$5.08K 0.04% 426
2023
Q2
$375K Sell
4,863
-4,240
-47% -$328K 0.04% 380
2023
Q1
$684K Sell
9,103
-542
-6% -$40.3K 0.04% 437
2022
Q4
$760K Buy
9,645
+367
+4% +$27.5K 0.05% 391
2022
Q3
$651K Buy
9,278
+1,119
+14% +$87.7K 0.04% 417
2022
Q2
$653K Buy
8,159
+131
+2% +$10.2K 0.04% 396
2022
Q1
$608K Buy
8,028
+294
+4% +$23.3K 0.04% 472
2021
Q4
$659K Buy
7,734
+44
+0.6% +$3.44K 0.04% 437
2021
Q3
$581K Sell
7,690
-31
-0.4% -$2.46K 0.04% 466
2021
Q2
$628K Buy
7,721
+2,871
+59% +$235K 0.05% 424
2021
Q1
$382K Sell
4,850
-272
-5% -$21.3K 0.03% 515
2020
Q4
$438K Buy
5,122
+1,347
+36% +$111K 0.04% 439
2020
Q3
$292K Buy
3,775
+311
+9% +$23.7K 0.03% 445
2020
Q2
$254K Buy
3,464
+218
+7% +$15.5K 0.03% 457
2020
Q1
$216K Buy
3,246
+209
+7% +$14.7K 0.04% 411
2019
Q4
$209K Buy
3,037
+1,155
+61% +$78.7K 0.03% 522
2019
Q3
$138K Buy
1,882
+42
+2% +$3.05K 0.02% 583
2019
Q2
$132K Sell
1,840
-335
-15% -$23.8K 0.03% 514
2019
Q1
$149K Sell
2,175
-4,927
-69% -$318K 0.03% 357
2018
Q4
$423K Buy
7,102
+4,681
+193% +$293K 0.11% 204
2018
Q3
$162K Sell
2,421
-6,190
-72% -$412K 0.03% 505
2018
Q2
$558K Buy
+8,611
New +$563K 0.16% 142
2017
Q4
Sell
-2,937
Closed -$214K 465
2017
Q3
$214K Buy
+2,937
New +$212K 0.05% 383

Other funds holding CL

Belpointe Asset Management's CL Position: Q1 2026 in Review

Belpointe Asset Management reduced its Colgate-Palmolive (CL) stake by 29% in Q1 2026, selling an estimated $208K and leaving 5,659 shares worth $482K. The position accounts for 0.02% of the portfolio, ranked #694.

Belpointe Asset Management first reported a position in CL in Q3 2017 and has held it in 33 quarters since. The position peaked at $1.07M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Belpointe Asset Management held 5,659 shares of Colgate-Palmolive worth $482K as of Q1 2026.
  • Belpointe Asset Management sold 2,339 Colgate-Palmolive shares in Q1 2026, an estimated $208K.
  • Colgate-Palmolive made up 0.02% of Belpointe Asset Management's portfolio in Q1 2026, its #694 holding.
  • Belpointe Asset Management first reported a position in Colgate-Palmolive in Q3 2017 and has held it in 33 quarters since.
  • Belpointe Asset Management's Colgate-Palmolive position peaked at $1.07M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Belpointe Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.